WT1 Peptide-Based Immunotherapy for Patients with Lung Cancer: Report of Two Cases

Microbiology and Immunology

Volumn 48, Issue 3, 2004, Pages 175-184

  Tsuboi, Akihiro ^a   Oka, Yoshihiro ^a   Osaki, Tadashi ^a   Kumagai, Toru ^a   Tachibana, Isao ^a   Hayashi, Seiji ^b   Murakami, Masaki ^a   Nakajima, Hiroko ^a   Elisseeva, Olga A ^a   Fei, Wu ^a   Masuda, Tomoki ^a   Yasukawa, Masaki ^c   Oji, Yusuke ^a   Kawakami, Manabu ^a   Hosen, Naoki ^a   Ikegame, Kazuhiro ^a   Yoshihara, Satoshi ^a   Udaka, Keiko ^d   Nakatsuka, Shin Ichi ^a   Aozasa, Katsuyuki ^a   Kawase, Ichiro ^a   Sugiyama, Haruo ^a   more..

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION KINKI CHUO CHEST MEDICAL CENTER   (Japan)

^c EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Immunotherapy; Lung cancer; Wilms' tumor gene; WT1

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; EMULSIFYING AGENT; HLA A ANTIGEN; MONTANIDE ISA51; SIALYL LEWIS X ANTIGEN; TUMOR MARKER; UNCLASSIFIED DRUG; WT1 PROTEIN;

ADULT; ADVANCED CANCER; AGED; ANTIGEN DETECTION; ARTICLE; BREAST CANCER; CANCER IMMUNOTHERAPY; CASE REPORT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; EMULSION; ERYTHEMA; FEMALE; GENE OVEREXPRESSION; HUMAN; INJECTION SITE; LUNG CANCER; MALE; NEPHROBLASTOMA; ONCOGENE; PEPTIDE ANALYSIS; PHASE 1 CLINICAL TRIAL; RESTRICTION FRAGMENT; SOLID TUMOR; TREATMENT OUTCOME; TUMOR VOLUME; VACCINATION; WT1 GENE;

EID: 12144291167     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2004.tb03503.x     Document Type: Article

References (38)

1. Brieger, J., Weidmann, E., Fenchel, K., Mitrou, P.S., Hoelzer, D., and Bergmann, L. 1994. The expression of the Wilms' tumor gene in acute myelocytic leukemias as a possible marker for leukemic blast cells. Leukemia 8: 2138-2143.
2. Call, K.M., Glaser, T., Ito, C.Y., Buckler, A.J., Pelletier, J., Haber, D.A., Rose, E.A., Kral, A., Yeger, H., Lewis, W.H., Jones, C., and Housman, D.E. 1990. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 60: 509-520.
3. Elisseeva, O.A., Oka, Y., Tsuboi, A., Ogata, K., Wu, F., Kim, E.H., Soma, T., Tamaki, H., Kawakami, M., Oji, Y., Hosen, N., Kubota, T., Nakagawa, M., Yamagami, T., Hiraoka, A., Tsukaguchi, M., Udaka, K., Ogawa, H., Kishimoto, T., Nomura, T., and Sugiyama, H. 2002. Humoral immune responses against Wilms tumor gene WT1 product in patients with hematopoietic malignancies. Blood 99: 3272-3279.
4. Gaiger, A., Reese, V., Disis, M.L., and Cheever, M.A. 2000. Immunity to WT1 in the animal model and in patients with acute myeloid leukemia. Blood 96: 1480-1489.
5. Gao, L., Bellantuono, I., Elsasser, A., Marley, S.B., Gordon, M.Y., Goldman, J.M., and Stauss, H.J. 2000. Selective elimination of leukemic CD34(+) progenitor cells by cytotoxic T lymphocytes specific for WT1. Blood 95: 2198-2203.
6. Gessler, M., Poustka, A., Cavenee, W., Neve, R.L., Orkin, S.H., and Bruns, G.A. 1990. Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature 343: 774-778.
7. b transgenic mice. Int. J. Cancer 100: 565-570.
8. Hosen, N., Sonoda, Y., Oji, Y., Kimura, T., Minamiguchi, H., Tamaki, H., Kawakami, M., Asada, M., Kanato, K., Motomura, M., Murakami, M., Fujioka, T., Masuda, T., Kim, E.H., Tsuboi, A., Oka, Y., Soma, T., Ogawa, H., and Sugiyama, H. 2002. Very low frequency of human normal CD34+ haematopoietic progenitor cells express the Wilms' tumour gene WT1 at levels similar to those in leukaemia cells. Br. J. Haematol. 116: 409-420.
9. Huang, A., Campbell, C.E., Bonetta, L., McAndrews-Hill, M.S., Chilton-MacNeill, S., Coppes, M.J., Law, D.J., Feinberg, A.P., Yeger, H., and Williams, B.R. 1990. Tissue, developmental, and tumor-specific expression of divergent transcripts in Wilms tumor. Science 250: 991-994.
10. + cytotoxic T lymphocytes. Int. J. Cancer 87: 553-558.
11. Inoue, K., Sugiyama, H., Ogawa, H., Nakagawa, M., Yamagami, T., Miwa, H., Kita, K., Hiraoka, A., Masaoka, T., Nasu, K., Kyo, T., Dohy, H., Nakauchi, H., Ishidate, T., Akiyama, T., and Kishimoto, T. 1994. WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia. Blood 84: 3071-3079.
12. Inoue, K., Ogawa, H., Sonoda, Y., Kimura, T., Sakabe, H., Oka, Y., Miyake, S., Tamaki, H., Oji, Y., Yamagami, T., Tatekawa, T., Soma, T., Kishimoto, T., and Sugiyama, H. 1997. Aberrant overexpression of the Wilms tumor gene (WT1) in human leukemia. Blood 89: 1405-1412.
13. Inoue, K., Tamaki, H., Ogawa, H., Oka, Y., Soma, T., Tatekawa, T., Oji, Y., Tsuboi, A., Kim, E.H., Kawakami, M., Akiyama, T., Kishimoto, T., and Sugiyama, H. 1998. Wilms' tumor gene (WT1) competes with differentiation-inducing signal in hematopoietic progenitor cells. Blood 91: 2969-2976.
14. Kreidberg, J.A., Sariola, H., Loring, J.M., Maeda, M., Pelletier, J., and Housman, D., and Jaenisch, R. 1993. WT-1 is required for early kidney development. Cell 74: 679-691.
15. Lee, K.H., Wang, E., Nielsen, M.B., Wunderlich, J., Migueles, S., Connors, M., Steinberg, S.M., Rosenberg, S.A., and Marincola, F.M. J. Immunol. 163: 6292-6300.
16. Makita, M., Hiraki, A., Azuma, T., Tsuboi, A., Oka, Y., Sugiyama, H., Fujita, S., Tanimoto, M., Harada, M., and Yasukawa, M. 2002. Antilung cancer effect of WT1-specific cytotoxic T lymphocytes. Clin. Cancer Res. 8: 2626-2631.
17. Menke, A.L., Van der Eb, A.J., and Jochemsen, A.G. 1998. The Wilms' tumor 1 gene: oncogene or tumor suppressor gene. Int. Rev. Cytol. 181: 151-212.
18. Menssen, H.D., Renkl, H.J., Rodeck, U., Maurer, J., Notter, M., Schwartz, S., Reinhardt, R., and Thiel, E. 1995. Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias. Leukemia 9: 1060-1067.
19. Miwa, H., Beran, M., and Saunders, G.F. 1992. Expression of the Wilms' tumor gene (WT1) in human leukemias. Leukemia 6: 405-409.
20. Miyagi, T., Ahuja, H., Kubota, T., Kubonishi, I., Koeffler, H.P., and Miyoshi, I. 1993. Expression of the candidate Wilm's tumor gene, WT1, in human leukemia cells. Leukemia 7: 970-977.
21. Miyoshi, Y., Ando, A., Egawa, C., Taguchi, T., Tamaki, Y., Tamaki, H., Sugiyama, H., and Noguchi, S. 2002. High expression of Wilms' tumor suppressor gene (WT1) predicts poor prognosis in breast cancer. Clin. Cancer Res. 8: 11.
22. Ohminami, H., Yasukawa, M., and Fujita, S. 2000. HLA class I-restricted lysis of leukemia cells by a CD8(+) cytotoxic T-lymphocyte clone specific for WT1 peptide. Blood 95: 286-293.
23. Oji, Y., Ogawa, H., Tamaki, H., Oka, Y., Tsuboi, A., Kim, E.H., Soma, T., Tatekawa, T., Kawakami, M., Asada, M., Kishimoto, T., and Sugiyama, H. 1999. Expression of the Wilms' tumor gene WT1 in solid tumors and its involvement in tumor cell growth. Jpn. J. Cancer Res. 90: 194-204.
24. Oji, Y., Miyoshi, S., Maeda, H., Hayashi, S., Tamaki, H., Nakatsuka, S., Yao, M., Takahashi, E., Nakano, Y., Hirabayashi, H., Shintani, Y., Oka, Y., Tsuboi, A., Hosen, N., Asada, M., Fujioka, T., Murakami, M., Kanato, K., Motomura, M., Kim, E.H., Kawakami, M., Ikegame, K., Ogawa, H., Aozasa, K., Kawase, I., and Sugiyama, H. 2002. Overexpression of the Wilms' tumor gene WT1 in de novo lung cancers. Int. J. Cancer 100: 297-303.
25. Oka, Y., Udaka, K., Tsuboi, A., Elisseeva, O.A., Ogawa, H., Aozasa, K., Kishimoto, T., and Sugiyama, H. 2000. Cancer immunotherapy targeting Wilms' tumor gene WT1 product. J. Immunol. 164: 1873-1880.
26. Oka, Y., Elisseeva, O.A., Tsuboi, A., Ogawa, H., Tamaki, H., Li, H., Oji, Y., Kim, E.H., Soma, T., Asada, M., Ueda, K., Maruya, E., Saji, H., Kishimoto, T., Udaka, K., and Sugiyama, H. 2000. Human cytotoxic T-lymphocyte responses specific for peptides of the wild-type Wilms' tumor gene (WT1) product. Immunogenetics 51: 99-107.
27. Oka, Y., Tsuboi, A., Elisseeva, O.A., Udaka, K., and Sugiyama, H. 2002. WT1 as a novel target antigen for cancer immunotherapy. Curr. Cancer Drug Targets 2: 45-54.
28. Pelletier, J., Schalling, M., Buckler, A.J., Rogers, A., Haber, D.A., and Housman, D. 1991. Expression of the Wilms' tumor gene WT1 in the murine urogenital system. Genes Dev. 5: 1345-1356.
29. Scheibenbogen, C., Letsch, A., Thiel, E., Schmittel, A., Mailaender, V., Baerwolf, S., Nagorsen, D., and Keilholz, U. 2002. CD8 T-cell responses to Wilms tumor gene product WT1 and proteinase 3 in patients with acute myeloid leukemia. Blood 100: 2132-2137.
30. Shichishima, T., Okamoto, M., Ikeda, K., Kaneshige, T., Sugiyama, H., Terasawa, T., Osumi, K., and Maruyama, Y. 2002. HLA class II haplotype and quantitation of WT1 RNA in Japanese patients with paroxysmal nocturnal hemoglobinuria. Blood 100: 22-28.
31. Sugiyama, H. 2001. Wilms' tumor gene WT1: its oncogenic function and clinical applicaion. Int. J. Hematol. 73: 177-187.
32. Sugiyama, H. 2002. Cancer immunotherapy targeting WT1 protein. Int. J. Hematol. 76: 127-132.
33. Tamaki, H., Ogawa, H., Ohyashiki, K., Ohyashiki, J.H., Iwama, H., Inoue, K., Soma, T., Oka, Y., Tatekawa, T., Oji, Y., Tsuboi, A., Kim, E.H., Kawakami, M., Fuchigami, K., Tomonaga, M., Toyama, K., Aozasa, K., Kishimoto, T., and Sugiyama, H. 1999. The Wilms' tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes. Leukemia 13: 393-399.
34. Tsuboi, A., Oka, Y., Ogawa, H., Elisseeva, O.A., Tamaki, H., Oji, Y., Kim, E.H., Soma, T., Tatekawa, T., Kawakami, M., Kishimoto, T., and Sugiyama, H. 1999. Constitutive expression of the Wilms' tumor gene WT1 inhibits the differentiation of myeloid progenitor cells but promotes their proliferation in response to granulocyte-colony stimulating factor (G-CSF). Leuk. Res. 23: 499-505.
35. Tsuboi, A., Oka, Y., Ogawa, H., Elisseeva, O.A., Li, H., Kawasaki, K., Aozasa, K., Kishimoto, T., Udaka, K., and Sugiyama, H. 2000. Cytotoxic T-lymphocyte responses elicited to Wilms' tumor gene WT1 product by DNA vaccination. J. Clin. Immunol. 20: 195-202.
36. Tsuboi, A., Oka, Y., Udaka, K., Murakami, M., Masuda, T., Nakano, A., Nakajima, H., Yasukawa, M., Hiraki, A., Oji, Y., Kawakami, M., Hosen, N., Fujioka, T., Wu, F., Taniguchi, Y., Nishida, S., Asada, M., Ogawa, H., Kawase, I., and Sugiyama, H. 2002. Enhanced induction of human WT1-specific cytotoxic T lymphocytes with a 9-mer WT1 peptide modified at HLA-A*2402-binding residues. Cancer Immunol. Immunother. 51: 614-620.
37. Wang, F., Bade, E., Kuniyoshi, C., Spears, L., Jeffery, G., Marty, V., Groshen, S., and Weber, J. 1999. Phase I trial of a MART-1 peptide vaccine with incomplete freunds' adjuvant for restricted high-risk melanoma. Clin. Cancer Res. 5: 2756-2765.
38. Yamagami, T., Sugiyama, H., Inoue, K., Ogawa, H., Tatekawa, T., Hirata, M., Kudoh, T., Akiyama, T., Murakami, A., and Maekawa, T. 1996. Growth inhibition of human leukemic cells by WT1 (Wilms tumor gene) antisense oligodeoxynucleotides: implications for the involvement of WT1 in leukemogenesis. Blood 87: 2878-2884.